Mirae Asset Global Investments Co. Ltd. Has $511,000 Stock Holdings in Avantor, Inc. (NYSE:AVTR)

Mirae Asset Global Investments Co. Ltd. trimmed its stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 56.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 31,543 shares of the company's stock after selling 41,071 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Avantor were worth $511,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Dodge & Cox boosted its stake in shares of Avantor by 44.9% during the 4th quarter. Dodge & Cox now owns 99,145,770 shares of the company's stock worth $2,089,001,000 after acquiring an additional 30,727,673 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC boosted its stake in shares of Avantor by 41.4% during the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 30,528,092 shares of the company's stock worth $643,227,000 after acquiring an additional 8,936,879 shares in the last quarter. Norges Bank bought a new stake in shares of Avantor during the 4th quarter worth $142,512,000. The Manufacturers Life Insurance Company boosted its stake in shares of Avantor by 48.3% during the 4th quarter. The Manufacturers Life Insurance Company now owns 9,158,175 shares of the company's stock worth $192,963,000 after acquiring an additional 2,983,439 shares in the last quarter. Finally, Clarkston Capital Partners LLC boosted its stake in shares of Avantor by 43.6% during the 4th quarter. Clarkston Capital Partners LLC now owns 8,145,825 shares of the company's stock worth $171,633,000 after acquiring an additional 2,473,395 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Avantor

In other news, Director Joseph R. Massaro purchased 8,100 shares of the firm's stock in a transaction dated Tuesday, April 29th. The stock was bought at an average price of $12.30 per share, with a total value of $99,630.00. Following the acquisition, the director directly owned 35,038 shares of the company's stock, valued at approximately $430,967.40. This represents a 30.07% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Gregory L. Summe purchased 30,000 shares of the firm's stock in a transaction dated Friday, May 23rd. The stock was purchased at an average cost of $12.50 per share, with a total value of $375,000.00. Following the acquisition, the director directly owned 100,000 shares in the company, valued at $1,250,000. This trade represents a 42.86% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 83,100 shares of company stock valued at $1,027,630 in the last quarter. Corporate insiders own 1.20% of the company's stock.

Analyst Upgrades and Downgrades

AVTR has been the subject of a number of research analyst reports. Robert W. Baird reduced their target price on Avantor from $21.00 to $17.00 and set an "outperform" rating for the company in a report on Monday, April 28th. The Goldman Sachs Group lowered Avantor from a "buy" rating to a "neutral" rating and reduced their target price for the company from $23.00 to $14.00 in a report on Tuesday, April 29th. Wells Fargo & Company reduced their target price on Avantor from $25.00 to $22.00 and set an "overweight" rating for the company in a report on Thursday, April 17th. Cowen lowered Avantor from a "buy" rating to a "hold" rating in a report on Monday, April 28th. Finally, TD Cowen lowered Avantor from a "buy" rating to a "hold" rating and set a $15.50 target price for the company. in a report on Monday, April 28th. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $18.14.

Avantor Trading Down 2.4%

AVTR stock traded down $0.33 during trading on Monday, hitting $13.55. The company had a trading volume of 1,552,583 shares, compared to its average volume of 8,395,108. The company has a quick ratio of 0.75, a current ratio of 1.12 and a debt-to-equity ratio of 0.54. The firm has a 50-day moving average price of $13.13 and a 200-day moving average price of $16.55. Avantor, Inc. has a 12 month low of $11.82 and a 12 month high of $28.00. The stock has a market cap of $9.23 billion, a price-to-earnings ratio of 13.05, a PEG ratio of 1.47 and a beta of 1.05.

Avantor (NYSE:AVTR - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $0.23 EPS for the quarter, meeting the consensus estimate of $0.23. The company had revenue of $1.58 billion during the quarter, compared to analysts' expectations of $1.61 billion. Avantor had a net margin of 10.70% and a return on equity of 11.93%. The business's revenue for the quarter was down 5.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.22 EPS. As a group, analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.